Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 35.12
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Slightly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Sandu Pharmaceuticals Ltd. engages in the manufacture and marketing of Ayurvedic medicines. It offers its products under the Berbenteron suspension, Berbenteron tablets, Bilagyl, Debix, Elegance Oil, Ephenin, Haemol Forte, Madiphal Rasayan, Osteon D, Pregutero, Sarak, Shatari, Stresan, Jaundex, Vanari Kalpa, Vimfix, Whoopin and Pentazyme brands. The company was founded on May 10, 1899 and is...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral o
Data is available to registered users only
Buy
Sell